220 related articles for article (PubMed ID: 26765464)
1. Transformation of a Nonfunctional Paraganglioma With I-123 MIBG Scintigraphy Correlation: A Case Report.
Davalos EA; Cho J; Dave H; Shen H; Barank D; Shim J
Medicine (Baltimore); 2016 Jan; 95(2):e2501. PubMed ID: 26765464
[TBL] [Abstract][Full Text] [Related]
2. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
[TBL] [Abstract][Full Text] [Related]
3. MIBG Localization of a Subclinical Paraganglioma of the Bladder.
Mithqal A; Darvishi P; Rehm P
Clin Nucl Med; 2017 Apr; 42(4):e196-e198. PubMed ID: 28195902
[TBL] [Abstract][Full Text] [Related]
4. Value of 123I-MIBG Scintigraphy in Paraganglioma.
Milardovic R; Corssmit EP; Stokkel M
Neuroendocrinology; 2010; 91(1):94-100. PubMed ID: 19786729
[TBL] [Abstract][Full Text] [Related]
5. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
[TBL] [Abstract][Full Text] [Related]
6. [Scintigraphy with iodine-131 metaiodobenzylguanidine in the study of paraganglioma. Comparison between benign and malignant tumors].
Maurea S; Cuocolo A; Reynolds J; Keiser H; Neumann R; Salvatore M
Radiol Med; 1994 May; 87(5):688-93. PubMed ID: 8008902
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of Somatostatin Receptor Scintigraphy (Tc-[HYNIC, Tyr3]-Octreotide) and 123I-Metaiodobenzylguanidine Scintigraphy in Patients with SDHx Gene-Related Pheochromocytomas and Paragangliomas Detected by Computed Tomography.
Michałowska I; Ćwikła JB; Pęczkowska M; Furmanek MI; Buscombe JR; Michalski W; Prejbisz A; Szperl M; Malinoc A; Moczulski D; Szutkowski Z; Kawecki A; Antoniewicz J; Pęczkowski P; Lewczuk A; Otto M; Cichocki A; Bednarek-Tupikowska G; Kabat M; Janaszek-Sitkowska H; Przybyłowska K; Janas J; Neumann HP; Januszewicz A
Neuroendocrinology; 2015; 101(4):321-30. PubMed ID: 25791839
[TBL] [Abstract][Full Text] [Related]
8. Localization and treatment of familial malignant nonfunctional paraganglioma with iodine-131 MIBG: report of two cases.
Khafagi F; Egerton-Vernon J; van Doorn T; Foster W; McPhee IB; Allison RW
J Nucl Med; 1987 Apr; 28(4):528-31. PubMed ID: 2437268
[TBL] [Abstract][Full Text] [Related]
9. Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging.
Havekes B; Lai EW; Corssmit EP; Romijn JA; Timmers HJ; Pacak K
Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):419-29. PubMed ID: 19088695
[TBL] [Abstract][Full Text] [Related]
10. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.
Fottner C; Helisch A; Anlauf M; Rossmann H; Musholt TJ; Kreft A; Schadmand-Fischer S; Bartenstein P; Lackner KJ; Klöppel G; Schreckenberger M; Weber MM
J Clin Endocrinol Metab; 2010 Jun; 95(6):2800-10. PubMed ID: 20371665
[TBL] [Abstract][Full Text] [Related]
11. Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy.
Quint LE; Glazer GM; Francis IR; Shapiro B; Chenevert TL
Radiology; 1987 Oct; 165(1):89-93. PubMed ID: 3628794
[TBL] [Abstract][Full Text] [Related]
12. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
[TBL] [Abstract][Full Text] [Related]
13. 111In-octreotide is superior to 123I-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas.
Koopmans KP; Jager PL; Kema IP; Kerstens MN; Albers F; Dullaart RP
J Nucl Med; 2008 Aug; 49(8):1232-7. PubMed ID: 18632829
[TBL] [Abstract][Full Text] [Related]
14. Pre- and post-treatment distribution pattern of 123I-MIBG in patients with phaeochromocytomas and paragangliomas.
Sinclair AJ; Bomanji J; Harris P; Ross G; Besser GM; Britton KE
Nucl Med Commun; 1989 Aug; 10(8):567-76. PubMed ID: 2812639
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of extra-adrenal paragangliomas by 131I-MIBG scintigraphy].
Yoshikawa T; Inaba S; Nagai T; Terai T; Ishimaru O; Yamaguchi J; Tsukamoto E; Furudate M
Rinsho Hoshasen; 1988 Oct; 33(10):1151-4. PubMed ID: 2850374
[No Abstract] [Full Text] [Related]
16. Uptake of iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison.
Bomanji J; Levison DA; Flatman WD; Horne T; Bouloux PM; Ross G; Britton KE; Besser GM
J Nucl Med; 1987 Jun; 28(6):973-8. PubMed ID: 3585505
[TBL] [Abstract][Full Text] [Related]
17. Whole-body iodine-131 metaiodobenzylguanidine imaging for detection of bone metastases in patients with paraganglioma: comparison with bone scintigraphy.
Inoue T; Yoshinaga K; Morita K; Shiga T; Kanegae K; Hirata K; Okamoto S; Tamaki N
Ann Nucl Med; 2007 Jul; 21(5):307-10. PubMed ID: 17634850
[TBL] [Abstract][Full Text] [Related]
18. Tumour size: the only predictive factor for 131I MIBG uptake in phaeochromocytoma and paraganglioma.
Nguyen HH; Proye CA; Carnaille B; Combemale F; Pattou FN; Huglo D
Aust N Z J Surg; 1999 May; 69(5):350-3. PubMed ID: 10353549
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial.
Wiseman GA; Pacak K; O'Dorisio MS; Neumann DR; Waxman AD; Mankoff DA; Heiba SI; Serafini AN; Tumeh SS; Khutoryansky N; Jacobson AF
J Nucl Med; 2009 Sep; 50(9):1448-54. PubMed ID: 19690028
[TBL] [Abstract][Full Text] [Related]
20. Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI.
Maurea S; Cuocolo A; Reynolds JC; Tumeh SS; Begley MG; Linehan WM; Norton JA; Walther MM; Keiser HR; Neumann RD
J Nucl Med; 1993 Feb; 34(2):173-9. PubMed ID: 8381474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]